Net Cash Provided by (Used in) Operating Activities |
-40.2M |
USD |
-210% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
78.5M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
7.3M |
USD |
-92.7% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
2.58M |
shares |
+0.27% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-52.3M |
USD |
-179% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
338M |
USD |
+32.4% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
15.9M |
USD |
-4.79% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
89.2M |
USD |
-23.2% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
177M |
USD |
-36% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
35.5M |
USD |
+61.4% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
124M |
USD |
|
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-3.6M |
USD |
-163% |
Q1 2023 |
Q1 2023 |
Additional Paid in Capital |
574M |
USD |
+2.74% |
Q2 2025 |
Q2 2025 |
Amortization of Intangible Assets |
21M |
USD |
+46.9% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
88.2M |
USD |
-45.3% |
Q4 2024 |
FY 2024 |
Interest Expense |
67.2M |
USD |
+5.83% |
Q2 2025 |
Q2 2025 |